Skip to main content
Jason Elinoff, MD, Pulmonology, Bethesda, MD

JasonElinoffMD

Pulmonology Bethesda, MD

Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine

CCMD

Dr. Elinoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Elinoff's full profile

Already have an account?

  • Office

    National Institutes of Health
    10 Center DR Bldg 10 RM 2C145
    Bethesda, MD 20892
    Phone+1 301-496-9320

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2007
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2004

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2008 - 2026
  • MA State Medical License
    MA State Medical License 2006 - 2009
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • Zymedi Announced Their Collaboration with the National Heart, Lung, and Blood Institute Through a CTA CRADA to Develop ZMA001 mAb, a Potential Treatment for Pulmonary Arterial Hypertension (PAH), a Rare, Female Predominant Disease
    Zymedi Announced Their Collaboration with the National Heart, Lung, and Blood Institute Through a CTA CRADA to Develop ZMA001 mAb, a Potential Treatment for Pulmonary Arterial Hypertension (PAH), a Rare, Female Predominant DiseaseJuly 3rd, 2023